ANNOUNCEMENTS
Neuroblastoma, a pediatric cancer derived from neural crest cells, presents significant challenges in treatment and understanding its differentiation pathways. This study explores the effects of all-trans retinoic acid (RA) on SH-SY5Y cells, a well-established in vitro model for neuronal differentiation. This study also presents compelling evidence for the successful differentiation of SH-SY5Y neuroblastoma cells, transitioning from an initial epithelial-like phenotype to a more complex and branched neuronal phenotype. Over a treatment period of 7 days, we employed phase-contrast microscopy and quantitative neurite outgrowth analysis to evaluate morphological changes, while biochemical characterization involved assessing neuronal markers such as MAP2, neuropeptide Y, DCX through immunocytochemistry. Results demonstrated significant neurite extension, decreased cell proliferation, and increased expression of neuronal markers, indicating successful differentiation towards a mature neuronal phenotype. These findings not only confirm the efficacy of RA in promoting SH-SY5Y cell differentiation but also underscore the potential of RA-differe ntiated cells as a valuable model for investigating neuronal function and the underlying mechanisms of neuroblastoma differentiation therapy.
The findings underscore the potential of SH-SY5Y cells as a model for neurodevelopmental studies and highlight the mechanisms that drive neuronal differentiation, which could inform future therapeutic strategies for neurodegenerative diseases.
The results contribute to a deeper understanding of neuronal plasticity and the developmental pathways of neuroblastoma cells.
Keywords: SH-SY5Y, Neuroblastoma, Retinoic acid, Neuronal differentiation.
